![Carole Faig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carole Faig
Directeur/Membre du Conseil chez
HENRY SCHEIN, INC.
Fortune : 614 555 $ au 31/05/2026
Profil
Carole T.
Faig currently works at Henry Schein, Inc., as Independent Director from 2023, QuVa Pharma, Inc., as Director, Affinia Therapeutics, Inc., as Independent Director from 2021, Program for Appropriate Technology in Health, as Director from 2022, and The Scan Group, Inc., as Director from 2025.
Ms. Faig also formerly worked at Cue Health, Inc., as Independent Director from 2021 to 2024 and Ernst & Young LLP, as Partner from 1997 to 2020.
Ms. Faig received her undergraduate degree from Sam Houston State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HENRY SCHEIN, INC. 0,01% | 23/03/2026 | 8 025 ( 0,01% ) | 614 555 $ | 31/05/2026 |
Postes actifs de Carole Faig
| Sociétés | Poste | Début |
|---|---|---|
| HENRY SCHEIN, INC. | Directeur/Membre du Conseil | 18/12/2023 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Directeur/Membre du Conseil | 01/09/2021 |
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Directeur/Membre du Conseil | - |
Program for Appropriate Technology in Health
 Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Provides social healthcare services | Directeur/Membre du Conseil | 01/12/2022 |
The Scan Group, Inc.
 The Scan Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, digital marketing, graphic design and printing services | Directeur/Membre du Conseil | 01/02/2025 |
Anciens postes connus de Carole Faig
| Sociétés | Poste | Fin |
|---|---|---|
| CUE HEALTH INC. | Directeur/Membre du Conseil | 24/05/2024 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/01/2020 |
Formation de Carole Faig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Henry Schein, Inc.
 Henry Schein, Inc. Medical DistributorsDistribution Services Distributes healthcare products and services | Distribution Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Sam Houston State University
 Sam Houston State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Program for Appropriate Technology in Health
Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Provides social healthcare services | Commercial Services |
The Scan Group, Inc.
The Scan Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, digital marketing, graphic design and printing services | Commercial Services |
Cue Health, Inc.
 Cue Health, Inc. Medical SpecialtiesHealth Technology Develops a wireless diagnostic device that enables consumers to run clinical lab tests at home to measure their own health | Health Technology |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
